2025, Number 1
<< Back
Dermatología Cosmética, Médica y Quirúrgica 2025; 23 (1)
What is your diagnosis? / Marjolin’s ulcer
Figueroa HMF, Uriarte RK, Ríos VF, Shuchleib CM, Hernández VM, Berumen GC, Vega MME
Language: Spanish
References: 8
Page: 81-82
PDF size: 78.64 Kb.
Text Extraction
No abstract.
REFERENCES
Kowal-Vern A y Criswell BK, Burn scar neoplasms: a literaturereview and statistical analysis, Burns 2005; 31:403-13.
Fleming MD, Hunt JL, Purdue GF y Sandstad J, Marjolin’s ulcer:a review and reevaluation of a difficult problem, J Burn CareRehabil 1990; 11:460-9.
Holterhues C, De Vries E, Louwman MW, Koljenovic´ S et al.,Incidencia y tendencias de neoplasias malignas cutáneas en losPaíses Bajos, 1989-2005, J Invest Dermatol 2010; 130:1807-12.
Guenther N, Menenakos C, Braumann C y Buettemeyer R,Squamous cell carcinoma arising on a skin graft 64 years afterprimary injury, Dermatol Online J 2007; 13:27.
Yu N, Long X, Luján-Hernández JR, Hassan KZ, Bai M, WangY, Wang X y Zhao R, Marjolin’s ulcer: a preventable malignancyarising from scars, World J Surg Oncol 2013; 11:313.
Saaiq M y Ashraf B, Marjolin’s ulcers in the post-burned lesionsand scars, World J Clin Cases 2014; 2(10):507-14.
Ozek C, Cankayali R, Bilkay U, Guner U, Gundogan H y SongurE, Marjolin’s ulcers arising in burn scars, J Burn Care Rehabil2001; 22:384-9.
Rowe DE, Carroll RJ y Day CL Jr, Prognostic factors for localrecurrence, metastasis, and survival rates in squamous cellcarcinoma of the skin, ear, and lip. Implications for treatmentmodality selection, J Am Acad Dermatol 1992; 26:976-90.